Which condition can be associated with systemic symptoms and is characterized by granulomatous inflammation of the eyes?

Study for the Common Eye Disorders Test. Enhance your understanding with flashcards and multiple choice questions, complete with detailed explanations and insights. Prepare thoroughly for your exam!

Multiple Choice

Which condition can be associated with systemic symptoms and is characterized by granulomatous inflammation of the eyes?

Explanation:
Granulomatous inflammation in the eye that comes with systemic symptoms points to sarcoidosis. Sarcoidosis is a multisystem inflammatory disease characterized by noncaseating granulomas in affected organs, and the eyes are a common site of involvement, often presenting as granulomatous uveitis. Patients may also have systemic signs such as cough, fever, fatigue, weight loss, and lymphadenopathy. This combination—eye inflammation with granulomas plus systemic features—best fits sarcoidosis. By contrast, retinal vascular occlusion is a localized retinal ischemic event, optic neuritis is inflammatory but not typically granulomatous and not inherently systemic, and a premature baby is not a disease that explains granulomatous eye inflammation.

Granulomatous inflammation in the eye that comes with systemic symptoms points to sarcoidosis. Sarcoidosis is a multisystem inflammatory disease characterized by noncaseating granulomas in affected organs, and the eyes are a common site of involvement, often presenting as granulomatous uveitis. Patients may also have systemic signs such as cough, fever, fatigue, weight loss, and lymphadenopathy. This combination—eye inflammation with granulomas plus systemic features—best fits sarcoidosis. By contrast, retinal vascular occlusion is a localized retinal ischemic event, optic neuritis is inflammatory but not typically granulomatous and not inherently systemic, and a premature baby is not a disease that explains granulomatous eye inflammation.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy